长春高新(000661.SZ)：金赛药业GenSci141软膏注册临床试验申请获得受理

Core Viewpoint - Changchun High-tech (000661.SZ) announced that its subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (referred to as "Jinsai Pharmaceutical"), has received the Acceptance Notice from the National Medical Products Administration for the clinical trial application of GenSci141 ointment [1] Group 1 - Jinsai Pharmaceutical's GenSci141 ointment is a dihydrotestosterone ointment designed to act through paracrine mechanisms in target tissues [1] - The product falls under chemical drugs categories 2.2 and 2.4 [1]